Elevated plasma 2-hydroxyglutarate in acute myeloid leukaemia: Association with the IDH1 SNP rs11554137 and severe renal impairment

British Journal of Haematology

Volumn 166, Issue 1, 2014, Pages 145-148

  Wiseman, Daniel H ^a   Small, Helen F ^a   Wilks, Deepti P ^a   Waddell, Ian D ^a   Dennis, Michael W ^b   Ogilvie, Donald J ^a   Somervaille, Tim C P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

2 hydroxyglutarate; Acute myeloid leukaemia; Isocitrate dehydrogenase; Rs11554137

Indexed keywords

2 HYDROXYGLUTARIC ACID; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER PROGNOSIS; DISEASE ASSOCIATION; EXON; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GLOMERULUS FILTRATION RATE; HETEROZYGOSITY; HUMAN; IDH1 GENE; IDH2 GENE; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEVERE RENAL IMPAIRMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY;

2-HYDROXYGLUTARATE; ACUTE MYELOID LEUKAEMIA; ISOCITRATE DEHYDROGENASE; RS11554137;

ACUTE KIDNEY INJURY; GLUTARATES; HUMANS; ISOCITRATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84902315815     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12826     Document Type: Article

References (9)

1. DiNardo, C.D., Propert, K.J., Loren, A.W., Paietta, E., Sun, Z., Levine, R.L., Straley, K.S., Yen, K., Patel, J.P., Agresta, S., Abdel-Wahab, O., Perl, A.E., Litzow, M.R., Rowe, J.M., Lazarus, H.M., Fernandez, H.F., Margolis, D.J., Tallman, M.S., Luger, S.M. & Carroll, M. (2013) Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood, 121, 4917-4924.
2. Fathi, A.T., Sadrzadeh, H., Borger, D.R., Ballen, K.K., Amrein, P.C., Attar, E.C., Foster, J., Burke, M., Lopez, H.U., Matulis, C.R., Edmonds, K.M., Iafrate, A.J., Straley, K.S., Yen, K.E., Agresta, S., Schenkein, D.P., Hill, C., Emadi, A., Neuberg, D.S., Stone, R.M. & Chen, Y.B. (2012) Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. Blood, 120, 4649-4652.
3. Ho, P.A., Kopecky, K.J., Alonzo, T.A., Gerbing, R.B., Miller, K.L., Kuhn, J., Zeng, R., Ries, R.E., Raimondi, S.C., Hirsch, B.A., Oehler, V., Hurwitz, C.A., Franklin, J.L., Gamis, A.S., Petersdorf, S.H., Anderson, J.E., Godwin, J.E., Reaman, G.H., Willman, C.L., Bernstein, I.D., Radich, J.P., Appelbaum, F.R., Stirewalt, D.L. & Meshinchi, S. (2011) Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG. Blood, 118, 4561-4566.
4. Janin, M., Mylonas, E., Saada, V., Micol, J.B., Renneville, A., Quivoron, C., Koscielny, S., Scourzic, L., Forget, S., Pautas, C., Caillot, D., Preudhomme, C., Dombret, H., Berthon, C., Barouki, R., Rabier, D., Auger, N., Griscelli, F., Chachaty, E., Leclercq, E., Courtier, M.H., Bennaceur-Griscelli, A., Solary, E., Bernard, O.A., Penard-Lacronique, V., Ottolenghi, C. & de Botton, S. (2014) Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: a Study by the Acute Leukemia French Association Group. Journal of Clinical Oncology, 32, 297-305.
5. Kimchi-Sarfaty, C., Oh, J.M., Kim, I.-W., Sauna, Z.E., Calcagno, A.M., Ambudkar, S.V. & Gottesman, M.M. (2007) A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525-528.
6. Losman, J.-A. & Kaelin, W.G. (2013) What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes & Development, 27, 836-852.
7. Wagner, K., Damm, F., Göhring, G., Görlich, K., Heuser, M., Schäfer, I., Ottmann, O., Lübbert, M., Heit, W., Kanz, L., Schlimok, G., Raghavachar, A.A., Fiedler, W., Kirchner, H.H., Brugger, W., Zucknick, M., Schlegelberger, B., Heil, G., Ganser, A. & Krauter, J. (2010) Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. Journal of Clinical Oncology, 28, 2356-2364.
8. Wang, J.H., Chen, W.L., Li, J.M., Wu, S.F., Chen, T.L., Zhu, Y.M., Zhang, W.N., Li, Y., Qiu, Y.P., Zhao, A.H., Mi, J.Q., Jin, J., Wang, Y.G., Ma, Q.L., Huang, H., Wu, D.P., Wang, Q.R., Yan, X.J., Yan, J.S., Li, J.Y., Wang, S., Huang, X.J., Wang, B.S., Jia, W., Shen, Y., Chen, Z. & Chen, S.J. (2013) Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. Proceedings of the National Academy of Sciences of the USA, 110, 17017-17022.
9. Ward, P.S., Lu, C., Cross, J.R., Abdel-Wahab, O., Levine, R.L., Schwartz, G.K. & Thompson, C.B. (2013) The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. The Journal of Biological Chemistry, 288, 3804-3815.